CALL US

News

ACRP Features Schulman IRB Biosafety Officer

Daniel Eisenman, PhD, RBP, SM(NRCM), CBSP, Biosafety Officer at Schulman IRB, discusses the emphasis on biosafety in clinical trials in an ACRP article.

READ MORE

Exclusive Free Symposium on Federal Initiatives Toward Single IRB Review

Schulman IRB Connections Presents: Emerging Issues in Research – Federal Initiatives Toward Single IRB Review Join industry colleagues February 15 for an interactive presentation and discussion of emerging issues in research. *This event has concluded. Thanks to everyone who joined the conversation in Boston!* Recent federal initiatives make it clear that the US government favors […]

READ MORE

Applied Clinical Trials Features Article on 21st Century Cures Act

Applied Clinical Trials recently featured an article written by Michele Russell-Einhorn that outlines the provisions of the 21st Century Cures Act.

READ MORE

Schulman IRB Adds Biosafety Officer to Team

Schulman IRB announces that Daniel Eisenman, Ph.D., RBP, SM(NRCM), CBSP, has joined the organization as Biosafety Officer.

READ MORE

Schulman IRB Becomes Veeva Technology Partner

Schulman IRB, the industry-leading central IRB in customer service and technology, announces its integration with Veeva Systems.

READ MORE

Final Revisions to Common Rule Now Available

HHS and 15 other federal agencies have issued the final rule to update US regulations that safeguard research participants.

READ MORE

Study Change and Product Safety Forms Now Available as SmartForms

Beginning January 18, Schulman will offer SmartForms to submit product safety materials as well as study change information. This includes items like study amendments, revisions to previously approved materials, investigator changes and site location changes. These intuitive, web-based forms present users with only applicable questions based on how they answered previous questions, reducing confusion and […]

READ MORE

NIH Extends Effective Date of New Single IRB Policy

After finalizing the new policy regarding the use of a single IRB for multi-site research, the NIH announced the effective date will be pushed back.

READ MORE